Progesterone+ References

  1. Baerwald AR et al. Form and function of the corpus luteum during the human menstrual cycle. Ultrasound Obstet Gynecol. 2005; 25(5): 498-507.
  2. Seifert-Klauss V and Prior JC. Progesterone and bone: Actions promoting bone health in women. J Osteoporos. 2010; 2010: 845180.
  3. Lei B et al. Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One. 2014; 9(7): e103969.
  4. Li Y et al. Progesterone alleviates endometriosis via inhibition of uterine cell proliferation, inflammation, and angiogenesis in an immunocompetent mouse model. PLoS One. 2016; 11(10): e0165347.
  5. Pengo MF et al. Sleep in women across the life span. Chest. 2018; 154(1): 196-206.
  6. Moore LB et al. Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands. J Biol Chem. 2000; 275(20): 15122-15127.
  7. Turkmen S et al. Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol. 2011; 162(2): 311-327.
  8. Pinna G et al. Allopregnanolone (1938–2019): A trajectory of 80 years of outstanding scientific achievements. Neurobiol Stress. 2020; 100246.
  9. Roomruangwong C et al. Lowered steady-state plasma levels of progesterone combined with declining progesterone levels during the luteal phase predict peri-menstrual syndrome and its major subdomains. Front Psychol. 2019; 10: 2446.
  10. Roomruangwong C et al. The menstrual cycle may not be limited to the endometrium but also may impact gut permeability. Acta Neuropsychiatrica 2019.
  11. Cable JK and Grider MH. Progesterone physiology. StatPearls.2021. https://www.ncbi.nlm.nih.gov/books/NBK558960/.
  12. Prior JC. Progesterone for Symptomatic Perimenopause Treatment – Progesterone politics, physiology and potential for perimenopause. Facts Views Vis Obgyn. 2011; 3(2): 109-120.
  13. Datta M et al. Thyroid hormone stimulates progesterone release from human luteal cells by generating a proteinaceous factor. J Endocrinol. 1998; 158(3): 319-325.
  14. Takahashi N et al. A potential role for endoplasmic reticulum stress in progesterone deficiency in obese women. Endocrinol. 2017; 158(1): 84-97.
  15. Fucic A et al. Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health. 2012; 11(Suppl 1): S8.
  16. Grantham JP et al. The estrogen hypothesis of obesity. PLoS One. 2014. https://doi.org/10.1371/journal.pone.0099776.
  17. Progestin (oral route, parenteral route, vaginal route). Mayo Clinic. Updated Sept 1, 2021. Accessed Sept 29, 2021. https://www.mayoclinic.org/drugs-supplements/progestin-oral-route-parenteral-route-vaginal-route/side-effects/drg-20069443.
  18. Paulson RJ et al. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J Clin Endocrinol Metab. 2014; 99(11): 4241-4249.